This is our library on scientific research related to CBD, the Endocannabinoid System, other cannabinoids and Heart Disease. Below you will find a list of conditions for which there are one or more scientific studies of CBD. The source of these scientific studies relates primarily to PubMed, an online service of the U.S. National Library of Medicine.
Important: The studies that are listed by PubMed are for the most part preclinical research. These relate in most cases to animal experiments with isolated CBD (pure CBD) and not fully extracted CBD extract. Although mammals have cell receptors that respond to cannabinoid compounds, the data collected from animal studies are not always 1: 1 applicable to humans. Always check with your physician before starting a new dietary supplement program. Learn more at: The Basics of CBD Oils and Cannabis as a Therapeutic Agent
- Acute administration of CBD in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
- Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
- CBD as an anti-arrhythmic, the role of the CB1 receptors
- CBD attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
- CBD protects against myocardial ischemic reperfusion injury
- Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
- Is the cardiovascular system a therapeutic target for CBD?
- Oleamide: A fatty acid amide signaling molecule in the cardiovascular system?
- Study: History Of Cannabis Use Associated With Increased Survival Rates Among Heart Attack Patients
- The Effect of CBD on Ischemia/Reperfusion-Induced Ventricular Arrhythmia